Related Experiment Video

Updated: May 3, 2026

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
13:24

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

14.0K

VarWalker: personalized mutation network analysis of putative cancer genes from next-generation sequencing data

Peilin Jia1, Zhongming Zhao2

  • 1Department of Biomedical Informatics, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America ; Center for Quantitative Sciences, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America.

Plos Computational Biology
|February 12, 2014
PubMed

Insights

Identifying cancer driver mutations is crucial for drug discovery. VarWalker, a novel network method, effectively prioritizes infrequently mutated driver genes by analyzing interactions, improving upon single-gene approaches.

Area of Science:

  • Genomics
  • Bioinformatics
  • Cancer Research

Background:

  • Interpreting next-generation sequencing (NGS) mutation data requires distinguishing driver from passenger mutations.
  • Current methods focusing on single-gene frequencies miss infrequently mutated driver genes and ignore gene interactions.
  • Identifying driver mutations is key for targeted therapies and new drug development.

Purpose of the Study:

  • To introduce VarWalker, a novel mutation network method for prioritizing driver genes in large-scale cancer mutation data.
  • To overcome limitations of single-gene frequency approaches by incorporating functional gene interconnections.
  • To enhance the identification of targetable genes and potential new cancer drugs.

Main Methods:

  • VarWalker utilizes generalized additive models based on sample-specific mutation profiles.
  • It builds on joint frequencies of mutated genes and their interactors identified via Random Walk with Restart in protein-protein interaction networks.
  • The method was applied to lung adenocarcinoma and melanoma datasets (>300 tumor genomes).

Main Results:

  • VarWalker successfully prioritized well-known, infrequently mutated driver genes by considering their interactions with recurrently mutated genes.
  • Consensus mutation subnetworks enriched with cancer genes and pathways were derived for specific cancer types.
  • Network-assisted approaches demonstrated effectiveness in detecting cancer driver genes in NGS data.

Conclusions:

  • VarWalker offers a powerful network-based approach to identify cancer driver genes from NGS data.
  • This method improves upon conventional single-gene analyses by capturing crucial gene network information.
  • VarWalker facilitates the discovery of novel, infrequently mutated driver genes for therapeutic targeting.

More Related Videos

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

26.1K
Comparative Lesions Analysis Through a Targeted Sequencing Approach08:16

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

6.2K

Related Concept Videos

Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.3K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
51.7K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
12.6K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.6K